About
45.03USD-0.16 -0.35%
Closed • Updated at 22:10 GMT+00:00Market Cap$3.59B
P/E Ratio41.45
Volume1.40M
Beta1.61
RSI73.75
Gross Margin69.97%
Veracyte, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
May 15 2026
Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer
May 5 2026
Veracyte Announces First Quarter 2026 Financial Results
Apr 28 2026
Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers
Apr 14 2026
Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026
Community Chat
Ask AI
Try asking
Translate